Cargando…

KRIPO – a structure-based pharmacophores approach explains polypharmacological effects

Detalles Bibliográficos
Autores principales:	Ritschel, Tina, Schirris, Tom JJ, Russel, Frans GM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980168/ https://www.ncbi.nlm.nih.gov/pubmed/24765125 http://dx.doi.org/10.1186/1758-2946-6-S1-O26

Ejemplares similares

Predicting drug polypharmacology using a novel surface property similarity-based approach
por: Perez-Nueno, Violeta I, et al.
Publicado: (2011)

In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014)

Generation of structure-based pharmacophores using energetic analysis – application on fragment docking
por: Loving, Kathryn, et al.
Publicado: (2011)

Virtual screening using structure-based consensus pharmacophore models and ensemble docking based on MD-generated conformations
por: Koch, Oliver, et al.
Publicado: (2011)

Combining pharmacophore- and MD-based modelling for phase II metabolism prediction
por: Rakers, Christin, et al.
Publicado: (2014)

Design of dual ligands using excessive pharmacophore query alignment
por: Moser, Daniel, et al.
Publicado: (2012)

Snooker Structure-Based Pharmacophore Model Explains Differences in Agonist and Blocker Binding to Bitter Receptor hTAS2R39
por: Roland, Wibke S. U., et al.
Publicado: (2015)

3D pharmacophore alignments: does improved geometric accuracy affect virtual screening performance?
por: Wolber, Gerhard, et al.
Publicado: (2010)

Structural and Functional View of Polypharmacology
por: Moya-García, Aurelio, et al.
Publicado: (2017)

Mitochondrial ADP/ATP exchange inhibition: a novel off-target mechanism underlying ibipinabant-induced myotoxicity
por: Schirris, Tom J. J., et al.
Publicado: (2015)

A comparison approach to explain risks related to x-ray imaging for scoliosis
por: Pace, N, et al.
Publicado: (2013)

Tautomerism in structure-based 3D pharmacophore modeling
por: Seidel, Thomas, et al.
Publicado: (2008)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

Household size explains successful malaria eradication
por: Hulden, Lena
Publicado: (2010)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Advances in Computational Polypharmacology
por: Feldmann, Christian, et al.
Publicado: (2022)

Computational model explaining two types of bursting found in inspiratory pacemakers.
por: Toporikova, Natalia, et al.
Publicado: (2010)

Hematocrit, iron and HDL-cholesterol explain 90% of variation in native blood T1
por: Rosmini, Stefania, et al.
Publicado: (2016)

Can the different presentation of the diabetic ischaemic foot be explained by different distributions of arterial disease
por: Pendry, Elizabeth, et al.
Publicado: (2010)

Sparse codes of harmonic sound and their interaction explain harmony-related response of auditory cortex
por: Terashima, Hiroki, et al.
Publicado: (2010)

Privileged Structures and Polypharmacology within and between Protein Families
por: Meyers, Joshua, et al.
Publicado: (2018)

Computational polypharmacology comes of age
por: Rastelli, Giulio, et al.
Publicado: (2015)

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring
por: Wolber, Gerhard
Publicado: (2008)

Polypharmacology Within the Full Kinome: a Machine Learning Approach
por: Jones, Derek, et al.
Publicado: (2018)

A simple mathematical approach to the analysis of polypharmacology and polyspecificity data
por: Maggiora, Gerry, et al.
Publicado: (2017)

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
por: Papa, Alessandro, et al.
Publicado: (2022)

How to pick a winning team: approaches towards the selection of computationally derived protein structures for ensemble-based virtual screening
por: Sander, Barbara, et al.
Publicado: (2013)

Fishing out the signal in polypharmacological high-throughput screening data using novel navigator cheminformatics software
por: Fourches, Denis, et al.
Publicado: (2014)

Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases
por: Baby, Bincy, et al.
Publicado: (2016)

Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets
por: Saqib, Uzma, et al.
Publicado: (2018)

Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology
por: Kampen, Stefanie, et al.
Publicado: (2021)

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
por: Clifford, GM, et al.
Publicado: (2009)

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
por: Chu, Ming, et al.
Publicado: (2018)

Automated design of ligands to polypharmacological profiles
por: Besnard, Jérémy, et al.
Publicado: (2012)

Exploiting kinase polypharmacology for nerve regeneration
por: Al-Ali, Hassan, et al.
Publicado: (2016)

How polypharmacologic is each chemogenomics library?
por: Ni, Eric, et al.
Publicado: (2020)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Polypharmacology: promises and new drugs in 2022
por: Ryszkiewicz, Piotr, et al.
Publicado: (2023)

Use of large multiconformational databases with structure-based pharmacophore models for fast screening of commercial compound collections
por: Del Rio, A, et al.
Publicado: (2011)

Aberrant activation of Notch signalling in human breast cancer
por: Stylianou, S, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_o1odiob4c274dmafjh18aqqegf